South East Asia gears up for common regulatory approach
This article was originally published in Clinica
There is a growing acceptance of the need for a joint approach to medical device regulation in South-East Asia. Pan-ASEAN co- operation in the regulatory field could accelerate the arrival of borderless trading within the region and offer enhanced business opportunities for device and diagnostics manufacturers.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.